Harmful gut microbes may have greater influence on immunotherapy for cancer patients than ‘good’ bacteria
A new study suggests that microorganisms which hinder the response to immunotherapy may have greater influence than beneficial microorganisms.
A new study suggests that microorganisms which hinder the response to immunotherapy may have greater influence than beneficial microorganisms.
New research reveals a link between the gut microbiome and how the body responds to immunotherapy for cancer.
Researchers and medical professionals are discovering a correlation between a diet rich in fiber and the effects of immunotherapy on patients with melanoma.